ACRO's advisory council chimes in on Big Pharma's R&D supergroup

The Association of Clinical Research Organizations (ACRO) assembled a group of CRO leaders to advise TransCelerate BioPharma, a nonprofit group run by the biggest names in drug development. At its inaugural meeting, the CRO Forum appointed executives from Quintiles ($Q) and INC Research ($INCR) to its leadership posts and picked senior subject matter experts to advise TransCelerate on its efforts to implement risk-based monitoring, site qualification, common protocols and shared quality-management systems. More